GelClinical Overview
Mouth Ulcer Gel (Choline Salicylate 8.7%-9% w/w, Benzalkonium Chloride 0.01% w/w, with or without Lignocaine 2% w/w) is a topical analgesic, anti-inflammatory, and antiseptic oral gel on the PMBI formulary. Choline salicylate is a topically absorbed non-steroidal anti-inflammatory that inhibits cyclooxygenase enzymes to relieve throbbing ulcer pain and swelling. Lignocaine produces rapid surface local anesthesia by blocking mucosal voltage-gated sodium channels. Benzalkonium chloride acts as a cationic surfactant bactericide, preventing secondary infection. Indicated for aphthous mouth ulcers, canker sores, denture sores, orthodontic abrasions, and herpes labialis irritation.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Wash hands thoroughly. Squeeze a small dab of gel onto the clean fingertip and apply gently directly over the ulcerated area every 3 to 4 hours as needed (up to 4 times daily). Avoid eating, drinking, or rinsing the mouth for 15 minutes after application.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Transient mild stinging or burning sensation upon initial application, temporary numbness of tongue and oral mucosa. Extremely safe with minimal systemic absorption.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Over-The-Counter oral ulcer gel. For topical oral use only; avoid swallowing large amounts. Not recommended in infants or children under 16 years with viral fever due to theoretical Reye's syndrome risk from salicylates.
Over-The-Counter (OTC)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Beclomethasone Dipropionate 0.025%, Clotrimazole 1% and Gentamicin Sulphate 0.1% Cream
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Beclomethasone 0.025% and Neomycin 0.5% Cream
Beclomethasone 0.025% and Neomycin 0.5% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Fusidic Acid Cream 2%
Fusidic Acid (2% w/w cream) is a steroid-like antibacterial agent that inhibits bacterial protein synthesis by interfering with elongation factor G (EF-G) on the ribosome. Highly active against Staphylococcus aureus, including methicillin-resistant strains (MRSA) and Corynebacterium species. Penetrates intact skin effectively. Indicated for impetigo, folliculitis, erythrasma, furunculosis, and infected wounds.
Povidone Iodine Ointment 5% w/w
Povidone Iodine Ointment 5% w/w is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.